|
US6083922A
(en)
*
|
1996-04-02 |
2000-07-04 |
Pathogenesis, Corp. |
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
|
|
US6076520A
(en)
*
|
1997-05-12 |
2000-06-20 |
Cooper; Emily L. |
Device for nasal therapeutic inhalation
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
TW465235B
(en)
|
1998-09-17 |
2001-11-21 |
United Video Properties Inc |
Electronic program guide with digital storage
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
CZ20012147A3
(cs)
*
|
1998-12-17 |
2003-01-15 |
Chiron Corporation |
Farmaceutický prostředek ve formě suchého práąku nebo rozpráąeného aerosolového prostředku pro léčení chronické bronchitidy
|
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
|
US8820316B2
(en)
*
|
2000-02-11 |
2014-09-02 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
|
ATE444771T1
(de)
*
|
2000-02-11 |
2009-10-15 |
Respironics Respiratory Drug D |
Wirkstoffabgabevorrichtung
|
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
|
US7971588B2
(en)
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
WO2001085136A2
(en)
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
PT2301524E
(pt)
*
|
2000-12-27 |
2013-07-10 |
Gilead Sciences Inc |
Aztreonam inalável sem arginina para tratamento e prevenção de infecções bacterianas pulmonares
|
|
US7214364B2
(en)
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
|
EP1598059A1
(en)
|
2001-05-18 |
2005-11-23 |
Chiron Corporation |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
|
JP2004534763A
(ja)
*
|
2001-05-18 |
2004-11-18 |
カイロン コーポレイション |
アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物
|
|
DE60103527T2
(de)
*
|
2001-07-02 |
2005-06-16 |
Chiesi Farmaceutici S.P.A. |
Optimierte Tobramycin-Formulierung zur Aerosolbildung
|
|
US20040022740A1
(en)
*
|
2001-07-10 |
2004-02-05 |
Baker William R. |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
|
MXPA04005865A
(es)
*
|
2001-12-19 |
2004-09-13 |
Nektar Therapeutics |
Suministro de aminoglucosidos a los pulmones.
|
|
MXPA04008372A
(es)
*
|
2002-03-01 |
2004-11-26 |
Chiesi Farma Spa |
Formulacion superfina de formoterol.
|
|
US8245708B2
(en)
*
|
2002-05-07 |
2012-08-21 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
AU2003238846A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Childrens Hospital And Regional Medical Center |
Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function
|
|
US6966649B2
(en)
*
|
2002-08-12 |
2005-11-22 |
John H Shadduck |
Adaptive optic lens system and method of use
|
|
US20040045546A1
(en)
*
|
2002-09-05 |
2004-03-11 |
Peirce Management, Llc |
Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
|
|
US7718189B2
(en)
*
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
AU2004281532B2
(en)
*
|
2003-10-15 |
2010-03-18 |
Pari Pharma Gmbh |
Liquid preparation containing tobramycin
|
|
BRPI0509026A
(pt)
|
2004-05-17 |
2007-09-18 |
Corus Pharma Inc |
formulação de aerossol, método para a prevenção e tratamento de infecção causada por bactéria do trato respiratório, e, solução
|
|
KR20070026604A
(ko)
*
|
2004-06-18 |
2007-03-08 |
노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 |
기관지 감염의 치료 방법
|
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
|
US8524735B2
(en)
*
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
US7838532B2
(en)
*
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
AU2013206401B2
(en)
*
|
2005-09-29 |
2016-06-23 |
Novartis Ag |
Antibiotic formulations, unit doses, kits, and methods
|
|
BRPI0616642A2
(pt)
*
|
2005-09-29 |
2011-06-28 |
Nektar Therapeutics |
formulações de antibióticos, doses unitárias, kits e métodos
|
|
ES2594368T3
(es)
|
2005-12-08 |
2016-12-19 |
Insmed Incorporated |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
WO2007070875A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Aerosol Science Laboratories, Inc. |
Treatment of active infections and related compositions
|
|
WO2007117550A2
(en)
*
|
2006-04-06 |
2007-10-18 |
Transave, Inc. |
Methods for coacervation induced liposomal encapsulation and formulations thereof
|
|
EP2012801A4
(en)
*
|
2006-04-24 |
2009-08-05 |
Gloucester Pharmaceuticals Inc |
GEMCITABINE COMBINATION THERAPY
|
|
PE20080712A1
(es)
*
|
2006-06-07 |
2008-05-22 |
Wyeth Corp |
Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador
|
|
WO2007145868A1
(en)
*
|
2006-06-07 |
2007-12-21 |
Wyeth |
Treating cystic fibrosis with antibiotics via an aerosol drug
|
|
US20070286817A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via a swirler delivery
|
|
US20070286818A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via an aerosol drug
|
|
WO2007146730A2
(en)
|
2006-06-08 |
2007-12-21 |
Gloucester Pharmaceuticals |
Deacetylase inhibitor therapy
|
|
US20080221132A1
(en)
|
2006-09-11 |
2008-09-11 |
Xiong Cai |
Multi-Functional Small Molecules as Anti-Proliferative Agents
|
|
MX2009003002A
(es)
*
|
2006-09-19 |
2009-06-01 |
Discovery Lab Inc |
Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.
|
|
JP2008199905A
(ja)
*
|
2007-02-16 |
2008-09-04 |
Snow Brand Milk Prod Co Ltd |
乳酸菌生残性向上剤
|
|
US20100196455A1
(en)
*
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
JP2010540526A
(ja)
*
|
2007-09-25 |
2010-12-24 |
ノバルティス アーゲー |
エアロゾル化されたバンコマイシンのような薬剤での肺障害の処置
|
|
AU2009246217B2
(en)
|
2008-05-15 |
2013-01-10 |
Novartis Ag |
Pulmonary delivery of a fluoroquinolone
|
|
WO2010042549A1
(en)
|
2008-10-07 |
2010-04-15 |
Mpex Pharmaceuticals, Inc. |
Inhalation of levofloxacin for reducing lung inflammation
|
|
HUE038428T2
(hu)
|
2008-10-07 |
2018-10-29 |
Horizon Orphan Llc |
Aeroszol fluorokinolon készítmények javított farmakokinetika érdekében
|
|
KR101411889B1
(ko)
|
2009-02-27 |
2014-06-27 |
이난타 파마슈티칼스, 인코포레이티드 |
Ｃ형 간염 바이러스 억제제
|
|
EP2408425A1
(en)
*
|
2009-03-20 |
2012-01-25 |
Livia Tiba |
Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution
|
|
PT2445502T
(pt)
|
2009-06-25 |
2017-09-22 |
Alkermes Pharma Ireland Ltd |
Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos
|
|
PT2473170T
(pt)
|
2009-09-04 |
2019-08-23 |
Horizon Orphan Llc |
Utilização de levofloxacina em aerossol para tratamento de fibrose cística
|
|
UA107095C2
(uk)
|
2009-12-14 |
2014-11-25 |
|
Антибіотичні мікрочастинки для інгаляції
|
|
AU2010339689B2
(en)
|
2010-01-07 |
2015-02-19 |
Alkermes Pharma Ireland Limited |
Quaternary ammonium salt prodrugs
|
|
EP2388008A1
(en)
|
2010-05-14 |
2011-11-23 |
Combino Pharm, S.L. |
Stable, preservative-free, aqueous formulation for the administration by aerosolization comprising tobramycin
|
|
CA2802733C
(en)
|
2010-06-24 |
2017-11-21 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
EP2593110B1
(en)
|
2010-07-12 |
2021-01-06 |
Xellia Pharmaceuticals ApS |
Treatment of lung infections by administration of tobramycin by aerolisation
|
|
WO2012088441A1
(en)
|
2010-12-23 |
2012-06-28 |
Alkermes, Inc. |
Multi- api loading prodrugs
|
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
|
CA2830822C
(en)
|
2011-04-01 |
2018-10-02 |
Curis, Inc. |
A thienopyrimidine phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
US8826904B2
(en)
|
2011-07-12 |
2014-09-09 |
Cardeas Pharma Corporation |
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
|
|
JP2014523909A
(ja)
|
2011-07-12 |
2014-09-18 |
カーディアス ファーマ コーポレイション |
人工呼吸器関連肺炎（ｖａｐ）及び人工呼吸器関連気管（ｖａｔ）気管支炎の治療のためのアミカシンとホスホマイシンの組み合わせの製剤並びに方法及びシステム
|
|
EP2567691B1
(en)
|
2011-09-12 |
2014-12-24 |
Meiji Seika Pharma Co., Ltd. |
Aqueous compositions comprising arbekacin
|
|
HUE044957T2
(hu)
|
2011-12-15 |
2019-11-28 |
Alkermes Pharma Ireland Ltd |
Samidorphan (ALKS 33) opioid agonistákkal alkotott kombinációja
|
|
EP2790734B1
(en)
|
2011-12-15 |
2019-02-20 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
GB201208080D0
(en)
|
2012-05-09 |
2012-06-20 |
Norton Healthcare Ltd |
Tobramycin formulation
|
|
HRP20220158T1
(hr)
|
2012-05-21 |
2022-04-15 |
Insmed Incorporated |
Sustavi za liječenje plućnih infekcija
|
|
CN102949379B
(zh)
*
|
2012-11-14 |
2014-11-05 |
中山大学 |
硫酸奈替米星吸入粉雾剂及其制备方法
|
|
CN104884047A
(zh)
|
2012-11-29 |
2015-09-02 |
英斯梅德股份有限公司 |
稳定的万古霉素制剂
|
|
EP2968285A4
(en)
|
2013-03-13 |
2016-12-21 |
Flatley Discovery Lab |
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
|
|
SG10201808565QA
(en)
|
2014-03-31 |
2018-11-29 |
Debiopharm Int Sa |
Fgfr fusions
|
|
CA2949078C
(en)
|
2014-05-15 |
2022-09-20 |
Insmed Incorporated |
Methods for treating pulmonary non-tuberculous mycobacterial infections
|
|
CN112870345A
(zh)
|
2014-08-26 |
2021-06-01 |
哈斯福制药公司 |
新型免疫剂及其使用方法
|
|
ES2971157T3
(es)
|
2014-10-06 |
2024-06-03 |
Apm Therapeutics 1 Inc |
Compuestos de triazolopiridina y métodos para el tratamiento de la fibrosis quística
|
|
WO2016089981A1
(en)
*
|
2014-12-04 |
2016-06-09 |
Carefusion 2200, Inc. |
Breath-actuated nebulizer for medicine inhalation
|
|
CN105616345B
(zh)
*
|
2016-03-01 |
2018-08-21 |
上海方予健康医药科技有限公司 |
一种妥布霉素吸入组合物及其制备方法和用途
|
|
ES2938341T3
(es)
|
2016-03-07 |
2023-04-10 |
Enanta Pharm Inc |
Agentes antivirales contra la hepatitis B
|
|
EP3512602B1
(en)
|
2016-09-16 |
2024-03-27 |
HSF Pharmaceuticals |
Inhibitors of heat shock factors (hsf) and uses thereof
|
|
EP3688184A1
(en)
*
|
2017-09-29 |
2020-08-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of developing pulmonary colonization/infection bypseudomonas aeruginosa
|
|
EP3762024A1
(en)
|
2018-03-08 |
2021-01-13 |
HSF Pharmaceuticals |
Localized activation of virus replication boosts herpesvirus-vectored vaccines
|
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
|
CA3096754A1
(en)
|
2018-05-10 |
2019-11-14 |
Cis Pharma Ag |
Biocompatible copolymer containing multiple active agent molecules
|
|
WO2020055840A1
(en)
|
2018-09-11 |
2020-03-19 |
Curis Inc. |
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
CN112955142A
(zh)
|
2018-09-21 |
2021-06-11 |
英安塔制药有限公司 |
官能化杂环化合物作为抗病毒剂
|
|
EP3653716A1
(en)
|
2018-11-19 |
2020-05-20 |
HSF Pharmaceuticals |
Replication-competent controlled alpha-herpesvirus virus vectors and uses therefore
|
|
GB2565941A
(en)
*
|
2018-11-27 |
2019-02-27 |
Norton Healthcare Ltd |
A process for preparing a formulation
|
|
US20220409737A1
(en)
|
2019-10-30 |
2022-12-29 |
Cis Pharma Ag |
Biocompatible polymeric drug carriers for delivering active agents
|
|
CN115003296A
(zh)
|
2019-12-05 |
2022-09-02 |
弗拉特利发现实验室有限责任公司 |
用于治疗囊肿状纤维化的化合物及其治疗方法
|
|
US20240229065A1
(en)
|
2020-04-24 |
2024-07-11 |
Hsf Pharmaceuticals Sa |
Replication-competent controlled herpesviruses expressing a sars cov-2 antigen
|
|
WO2021262799A1
(en)
|
2020-06-23 |
2021-12-30 |
Flagship Pioneering, Inc. |
Anti-viral compounds and methods of using same
|
|
ES2922973T1
(es)
|
2020-07-20 |
2022-09-22 |
Enanta Pharm Inc |
Peptidos funcionalizados como agentes antivirales
|
|
KR20230124582A
(ko)
|
2020-11-23 |
2023-08-25 |
이난타 파마슈티칼스, 인코포레이티드 |
신규한 스피로피롤리딘 유래 항바이러스제
|
|
WO2023006993A1
(en)
|
2021-07-30 |
2023-02-02 |
Atmosr |
Fused amino pyridine or pyrimidine derivatives for the treatment of congenital central hypoventilation syndrome
|
|
CN114177140A
(zh)
*
|
2021-12-10 |
2022-03-15 |
卓和药业集团股份有限公司 |
一种硫酸奈替米星气雾剂
|